Birbeck, G. L., French, J. A., Perucca, E., et al. Antiepileptic drug selection for people with HIV/AIDS: evidence-based guidelines from the ILAE and AAN. Epilepsia 2012; 53(1): 207–14.CrossRefGoogle ScholarPubMed

Chang, C. C., Sheikh, V., Sereti, I., and French, M. A. Immune reconstitution disorders in patients with HIV infection: from pathogenesis to prevention and treatment. Curr. HIV/AIDS Rep. 2014; 11(3): 223–32.CrossRefGoogle ScholarPubMed

Kirmani, B. F. and Mungall-Robinson, D. Role of anticonvulsants in the management of AIDS related seizures. Front. Neurol. 2014; 5: 10.CrossRefGoogle ScholarPubMed

Kranick, S. M. and Nath, A. Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy. Continuum (Minneapolis, MN) 2012; 18(6 Infectious Disease): 1319–37.Google ScholarPubMed

McArthur, J. and Smith, B. Neurologic complications and considerations in HIV-infected persons. Curr. Infect. Dis. Rep. 2013; 15(1): 61–6.CrossRefGoogle ScholarPubMed

McNicholl, I. R. and Peiperl, L. (eds.). HIV InSite Database of Antiretroviral Drug Interactions, http://hivinsite.ucsf.edu/arvdb?page=ar-0002 (accessed December 3, 2014).Google Scholar

Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America, https://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf (accessed March 8, 2018).Google Scholar

Perfect, J. R., Dismukes, W. E., Dromer, F., et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin. Inf. Dis. 2010; 50(3): 291–322.CrossRefGoogle ScholarPubMed

Price, R. W., Spudich, S. S., Peterson, J., et al. Evolving character of chronic central nervous system HIV infection. Semin. Neurol. 2014; 34(1): 7–13.Google ScholarPubMed

Quagliarello, V. Adjunctive steroids for tuberculous meningitis – more evidence, more questions. New Engl. J. Med. 2004; 351(17): 1792–4.CrossRefGoogle ScholarPubMed

Rothman, R. E., Keyl, P. M., McArthur, J. C., et al. A decision guideline for emergency department utilization of noncontrast head computerized tomography in HIV-infected patients. Acad. Emerg. Med. 1999; 6(10): 1010–19.CrossRefGoogle ScholarPubMed

Snider, W. D., Simpson, D. M., Nielsen, S., et al. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann. Neurol. 1983; 14(4): 403–18.CrossRefGoogle ScholarPubMed

Spudich, S. S., Nilsson, A. C., Lollo, N. D., et al. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infect. Dis. 2005; 5: 98.CrossRefGoogle ScholarPubMed

Tate, D. F., Khedraki, R., McCaffrey, D., et al. The role of medical imaging in defining CNS abnormalities associated with HIV-infection and opportunistic infections. Neurotherapeutics 2011; 8(1): 103–16.CrossRefGoogle ScholarPubMed

Treisman, G. J. and Kaplin, A. I. Neurologic and psychiatric complications of antiretroviral agents. AIDS 2002; 16(9): 1201–15.CrossRefGoogle ScholarPubMed

Tso, E. L., Todd, W. C., Groleau, G. A., and Hooper, F. J. Cranial computed tomography in the emergency department evaluation of HIV-infected patients with neurologic complaints. Ann. Emerg. Med. 1993; 27: 70–7.Google Scholar

Tunkel, A. R., Hartman, B. J., Kaplan, S. L., et al. Practice guidelines for the management of bacterial meningitis. Clin. Infect. Dis. 2004; 39(9): 1267–84.CrossRefGoogle ScholarPubMed